FSS rescues homocysteine-caused the decrease of NO production in cultured HUVECs after the application of A23187. by Cathy W. C. Bi (108697)

EPO administration does not decrease <i>Hamp</i> expression in <i>mask</i> mice. by Jana Frýdlová (163557)

FA decrease in 5STS impaired participants. by Charlotte Bernard (433013)

Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

Decrease in the hemolymph sugar level of hyperglycemic silkworms and increase in AMPK phosphorylation in the fat body by AICAR. by Yasuhiko Matsumoto (206628)

Blocking C5L2 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). by Jian Hao (160736)

H₂S is responsible for decreased active MMP-1/TIMP-1 ratio. by Ingrid Gomez (520676)

H₂S is responsible for decreased active MMP-1/TIMP-2 ratio. by Ingrid Gomez (520676)

Competition localization increases with growth rate or the distances between colonies, and decreases with the resource diffusion constant. by Jeremy M. Chacón (8259792)

Mean fecal egg count per individual before and after administration of a single oral dose albendazole. by Martin Walker (170282)

Resistance to Pap-A correlates with decreases in PS. by Chelsi D. Cassilly (2793433)

Decreased motor coordination deficits in <i>Cln6^nclf</i> mice. by Jeremy P. Morgan (479017)

Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

“…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”

SKO mice demonstrate increased cholesterol efflux in whole skin, and decreased cholesterol levels in plasma. by Sabrina N. Dumas (5474456)

Clinical and genetic characteristics of 5 patients harboring mutations in the <i>NR5A1</i> gene. by Jana Malikova (615672)

Subjects:

Decreased levels of PRMT1 alters BRCA1 promoter binding <i>in vivo.</i> by Irene Guendel (173419)

GAS5 levels are decreased in bladder cancer. by Zhihong Liu (112690)

Scara5 expression decreased during retinopathy. by Luísa Mendes-Jorge (635136)

“…C: The immunolabeling of paraffin-embedded retinal sections with anti-Scara5 antibody confirmed that Scara5 expression decreased throughout the parenchyma. …”

FG-2216 decreased plasma markers of cardiac injury in Nx-Ob-ZSF1 rats. by Pierre E. Signore (11218497)

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…<p>Immunofluorescent staining of guinea pig brain tissue for DAPI (blue) and claudin V (cyan) in vessels was performed. Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. …”